CROMOLYN SODIUM
PULMONARY MAST-CELL STABILIZER-TYPE ANTI-INFLAMMATORY AGENTS · SYSTEMIC MASTOCYTOSIS
MICRO LABS USA,
Drug class
Pulmonary Mast-Cell Stabilizer-Type Anti-Inflammatory Agents
While "Pulmonary Mast-Cell Stabilizer-Type Anti-Inflammatory Agents" is not a formal standalone heading established in official drug classification systems like the FDA Established Pharmacologic Class, it functionally describes inhaled mast cell stabilizers such as cromolyn sodium and nedocromil. Read more about Pulmonary Mast-Cell Stabilizer-Type Anti-Inflammatory Agents
3 drugs in this class 3 manufacturers
Drugs in Pulmonary Mast-Cell Stabilizer-Type Anti-Inflammatory Agents
CROMOLYN SODIUM
PULMONARY MAST-CELL STABILIZER-TYPE ANTI-INFLAMMATORY AGENTS · MAINTENANCE THERAPY FOR ASTHMA
BRYANT RANCH PR
CROMOLYN SODIUM
PULMONARY MAST-CELL STABILIZER-TYPE ANTI-INFLAMMATORY AGENTS · MAINTENANCE THERAPY FOR ASTHMA
RITEDOSE PHARMA
Filter & compare in the drug finder →
Opens the drug finder with Pulmonary Mast-Cell Stabilizer-Type Anti-Inflammatory Agents preselected. Add indication or manufacturer filters there.
While "Pulmonary Mast-Cell Stabilizer-Type Anti-Inflammatory Agents" is not a formal standalone heading established in official drug classification systems like the FDA Established Pharmacologic Class, it functionally describes inhaled mast cell stabilizers such as cromolyn sodium and nedocromil.
These non-steroidal agents act locally in the respiratory tract by inhibiting calcium influx into sensitized mast cells, thereby blocking degranulation and the subsequent release of histamine, leukotrienes, and other inflammatory mediators.
In clinical practice, they serve as long-term prophylactic maintenance therapies for mild persistent bronchial asthma and are used to prevent exercise-induced or allergen-triggered bronchospasm.
Because they lack intrinsic bronchodilating capacity, their therapeutic role is strictly preventative rather than indicated for acute bronchospasm relief.
-
fda.gov
While "Pulmonary Mast-Cell Stabilizer-Type Anti-Inflammatory Agents" is not a formal standalone heading established in official drug classification systems like the FDA Established Pharmacologic Class, it functionally describes inhaled mast cell stabilizers such as cromolyn sodium and nedocromil
-
researchgate.net
While "Pulmonary Mast-Cell Stabilizer-Type Anti-Inflammatory Agents" is not a formal standalone heading established in official drug classification systems like the FDA Established Pharmacologic Class, it functionally describes inhaled mast cell stabilizers such as cromolyn sodium and nedocromil
-
nih.gov
While "Pulmonary Mast-Cell Stabilizer-Type Anti-Inflammatory Agents" is not a formal standalone heading established in official drug classification systems like the FDA Established Pharmacologic Class, it functionally describes inhaled mast cell stabilizers such as cromolyn sodium and nedocromil These non-steroidal agents act locally in the respiratory tract by inhibiting calcium influx into sensitized mast cells, thereby blocking degranulation and the subsequent release of histamine, leukotrien...
-
medcentral.com
Because they lack intrinsic bronchodilating capacity, their therapeutic role is strictly preventative rather than indicated for acute bronchospasm relief
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.